LAKEWOOD, Colo., Feb. 16, 2023 /PRNewswire/ -- Today, Terumo Blood and Cell Technologies announces U.S. Food and Drug Administration (FDA) clearance and official launch of its IMUGARD ® WB Platelet ...
Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too. Promacta (eltrombopag) improved platelet counts in patients with ...
Terumo Blood and Cell Technologies has announced US Food and Drug Administration (FDA) clearance and official launch of its IMUGARD(R)WB Platelet Pooling Set, which supports extended shelf life of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results